drugset / Trial / NCT07513441
A Trial of Lu AF28996 in Participants With Parkinson's Disease (PD)
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to investigate the safety of Lu AF28996, how well it is tolerated and what the body does to the drug in participants with Parkinson's disease.
Timeline
- Start
- 2026-03-31
- Primary completion
- 2027-05-31
- Completion
- 2027-05-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lu AF28996 | Unknown | — | Oral |